© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Nutex Health, Inc. (NUTX) shows an Average True Range (ATR) of 14.87 and an Enterprise Value of 287.05M. Its average trading volume over the past 3 months is 152.79K, indicating liquidity. These fundamental metrics provide insight into NUTX's underlying financial health and market activity.
Nutex Health, Inc. (NUTX) technical indicators as of December 22, 2025: the SMA 20 is 12.13%, SMA 50 at 31.66%, and SMA 200 at 53.28%. The RSI 14 value is 59.54, suggesting its current momentum. These technical analysis signals help assess NUTX's price trends and potential future movements.
Nutex Health, Inc. (NUTX) stock performance overview as of December 22, 2025: The 52-week high is $193 (currently -10.92% below), and the 52-week low is $28.12 (currently 511.42% above). Over the past year, NUTX's performance is 391.65%, compared to the S&P 500's 12.87% change.
According to market data, Nutex Health, Inc. (NUTX) stock's recent performance metrics show that over the last month, NUTX is 73.32%, with a Year-to-Date (YTD) performance of 442.54%. Over the past year, the stock has seen a 391.65% change. These figures summarize NUTX's price movements across various periods, reflecting its historical returns.
According to current financial data, NUTX stock's P/E (TTM) ratio is 10.44, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for NUTX, including P/S (1.08), P/B (3.75), and P/FCF (4.72), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.